This website uses cookies for improving and personalising our services and marketing.

Full information can be seen on our Privacy Policy.

Accept Cookies
Like Us!
Watch Us!
Follow Us!
Contact Us!

Providing enabling technologies to support you from Discovery to Delivery.

Esco Pharma News

News The Health Quarters: Strengthening cGMP compliance for Pharmaceutical Drugs and Biologics Manufacturing (Issue 4, March 2022)

The Health Quarters: Strengthening cGMP compliance for Pharmaceutical Drugs and Biologics Manufacturing (Issue 4, March 2022)

Share

The Health Quarters: Strengthening cGMP compliance for Pharmaceutical Drugs and Biologics Manufacturing (Issue 4, March 2022)

The fourth (4th) issue release of The Health Quarters (HQ) newsletter focuses and touches on a wide range of technologies and solutions for the manufacture of pharmaceutical drugs and biological products.


With the aim to strengthen the core of cGMP compliance in our clients’ manufacturing process, The HQ sheds light on Esco Aster joining the World Vaccine Congress for the 6th time on Apr. 18-21 at Marriott Marquis Washington DC, USA. Also, learn about our cGMP Cleanroom Solutions for COVID- Repurposed Drugs (RDs), Monoclonal Antibodies (mAbs), Vaccines, and Oral Solid Dosage (OSD) Antiviral Drugs as well as the ex-Cell-ent features of the Cell Processing Isolator, containing guides in choosing the right isolator for your cell therapy process.

Get a free copy of The HQ's newsletter and ensure cGMP compliance for your facilities!


Download Newsletter